Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAC in Cannabis Dependent Adolescents
NCT00542750Phase 2Completed
- Sponsor
- Medical University of South Carolina
- Start
- Jan 2008
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of acetylcysteine in cannabis use disorder (CUD), sponsored by Medical University of South Carolina. Primary endpoints: Feasibility of Recruitment, Measured by Number of Participants Recruited and Retained During Study Period at 1 year and Safety and Tolerability of NAC at 4 weeks. Started Jan 2008; status: completed.
02
Drugs
acetylcysteine
03
Conditions
cannabis use disorder (CUD)
Beyond the preview
Go deeper on NCT00542750.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00542750.